Multiple sclerosis / nausea

Amines that inhibit a mammalian anandamide transporter, and methods of use thereof

Only registered users can translate articles

Log In/Sign up

BACKGROUND OF THE INVENTION Mammalian Endogenous Cannabinoid System The various elements of the mammalian endogenous cannabinoid system (ECS) constitute a variety of pharmacological targets for the broad group of compounds generally termed as cannabinoids. Included among these elements are two types

Amines that inhibit a mammalian anandamide transporter, and methods of use thereof

Only registered users can translate articles

Log In/Sign up

BACKGROUND OF THE INVENTION Mammalian Endogenous Cannabinoid System The various elements of the mammalian endogenous cannabinoid system (ECS) constitute a variety of pharmacological targets for the broad group of compounds generally termed as cannabinoids. Included among these elements are two types

Amines that inhibit a mammalian anandamide transporter, and methods of use thereof

Only registered users can translate articles

Log In/Sign up

BACKGROUND OF THE INVENTION Mammalian Endogenous Cannabinoid System The various elements of the mammalian endogenous cannabinoid system (ECS) constitute a variety of pharmacological targets for the broad group of compounds generally termed as cannabinoids. Included among these elements are two types

Bisarylimidazolyl fatty acid amide hydrolase inhibitors

Only registered users can translate articles

Log In/Sign up

FIELD OF THE INVENTION The present invention relates to bisarylimidazolyl derivatives and pharmaceutical compositions comprising said derivatives which inhibit fatty acid amide hydrolase and are useful for the treatment of conditions affected by inhibiting fatty acid amide

Urea compounds and their use as enzyme inhibitors

Only registered users can translate articles

Log In/Sign up

FIELD OF THE INVENTION The present invention relates to compounds and their uses, and in particular to compounds and their therapeutic use in the treatment or prevention of conditions having an association with substrates, such as the neurotransmitter anandamide, which are broken down by the fatty

Urea compounds and their use as enzyme inhibitors

Only registered users can translate articles

Log In/Sign up

FIELD OF THE INVENTION The present invention relates to compounds and their uses, and in particular to compounds and their therapeutic use in the treatment or prevention of conditions having an association with substrates, such as the neurotransmitter anandamide, which are broken down by the fatty

4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB.sub.1 receptor modulators

Only registered users can translate articles

Log In/Sign up

The present disclosure relates to the fields of pharmaceutical and organic chemistry, and provides 4,5-dihydro-(1H)-pyrazole (pyrazoline) derivatives as cannabinoid CB.sub.1 receptor modulators, intermediates for synthesizing these compounds, formulations comprising these compounds, methods for

Bioceramic and carbon-based hydroponic systems, methods and devices

Only registered users can translate articles

Log In/Sign up

BACKGROUND Agriculture is the cultivation and breeding of animals, plants and fungi for food, fiber, biofuel, medicinal plants and others. The dominant agricultural methodology in modern times, often referred to as industrial agriculture, is typically based on large-scale monoculture farming and

Compressed tablet containing .DELTA.9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment

Only registered users can translate articles

Log In/Sign up

CROSS-REFERENCE TO RELATED APPLICATIONS This application is the U.S. National Phase of International Patent Application No. PCT/NL2014/050746, filed Oct. 29, 2014, published on May 7, 2015 as WO 2015/065180 A1, which claims priority to European Patent Application No. 13190577.0, filed Oct. 29, 2013.

Cannabimimetic lipid amides as useful medications

Only registered users can translate articles

Log In/Sign up

BACKGROUND OF THE INVENTION Classical cannabinoids such as the marijuana derived cannabinoid .DELTA..sup.9-tetrahydrocannabinol, (.DELTA..sup.9-THC) produce their pharmacological effects through interaction with specific cannabinoid receptors in the body. So far, two cannabinoid receptors have been

multiple sclerosis/nausea

Amines that inhibit a mammalian anandamide transporter, and methods of use thereof

Amines that inhibit a mammalian anandamide transporter, and methods of use thereof

Amines that inhibit a mammalian anandamide transporter, and methods of use thereof

Bisarylimidazolyl fatty acid amide hydrolase inhibitors

Urea compounds and their use as enzyme inhibitors

Urea compounds and their use as enzyme inhibitors

4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB.sub.1 receptor modulators

Bioceramic and carbon-based hydroponic systems, methods and devices

Compressed tablet containing .DELTA.9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment

Cannabimimetic lipid amides as useful medications

The most complete medicinal herbs database backed by science